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              The endothelium plays an important role in 
maintaining vascular homeostasis by synthesizing 
and releasing several vasodilators, including pros-
tacyclin (PGI  2  ), nitric oxide (NO), and endothe-
lium-derived hyperpolarizing factor (EDHF) 
(  1  –  3  ). It is widely accepted that EDHF plays an 
important role in modulating vascular tone, es-
pecially in microvessels (  4, 5  ). Since the fi  rst re-
ports on the existence of EDHF (  6, 7  ), several 
candidates for EDHF have been proposed, in-
cluding epoxyeicosatrienoic acids (  8, 9  ), potas-
sium ions (  10, 11  ), gap junctions (  12, 13  ), and, as 
we have identifi  ed, hydrogen peroxide (H  2  O  2  ) 
(  14  –  16  ). We have demonstrated that endothe-
lium-derived H  2  O  2   is an EDHF in mouse (  14  ) 
and human (  15  ) mesenteric arteries and porcine 
coronary microvessels (  16  ). Other investigators 
have subsequently confi  rmed the importance of 
H  2  O  2   as an EDHF in human (  17  ) and canine 
(  18, 19  ) coronary microvessels and piglet pial 
arteries (  20  ). We have also demonstrated that 
endothelial NO synthase (eNOS) is a major 
source of EDHF/H  2  O  2   (  14  ), where copper, 
zinc-superoxide dismutase (Cu,Zn-SOD) plays 
an important role to dismutate eNOS-derived 
superoxide anions to EDHF/H  2  O  2   in animals 
and humans (  21, 22  ). However, the mecha-
nism for the endothelial production of H  2  O  2   as 
an endogenous EDHF remains to be   elucidated. 
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  The endothelium plays an important role in maintaining vascular homeostasis by synthesiz-
ing and releasing several relaxing factors, such as prostacyclin, nitric oxide (NO), and 
endothelium-derived hyperpolarizing factor (EDHF). We have previously demonstrated in 
animals and humans that endothelium-derived hydrogen peroxide (H  2  O  2  ) is an EDHF that is 
produced in part by endothelial NO synthase (eNOS). In this study, we show that genetic 
disruption of all three NOS isoforms (neuronal [nNOS], inducible [iNOS], and endothelial 
[eNOS]) abolishes EDHF responses in mice. The contribution of the NOS system to EDHF-
mediated responses was examined in eNOS      /     , n/eNOS      /     , and n/i/eNOS      /      mice. EDHF-
mediated relaxation and hyperpolarization in response to acetylcholine of mesenteric 
arteries were progressively reduced as the number of disrupted NOS genes increased, 
whereas vascular smooth muscle function was preserved. Loss of eNOS expression alone 
was compensated for by other NOS genes, and endothelial cell production of H  2  O  2   and 
EDHF-mediated responses were completely absent in n/i/eNOS      /      mice, even after antihy-
pertensive treatment with hydralazine. NOS uncoupling was not involved, as modulation of 
tetrahydrobiopterin (BH  4  ) synthesis had no effect on EDHF-mediated relaxation, and the 
BH  4  /dihydrobiopterin (BH  2  ) ratio was comparable in mesenteric arteries and the aorta. 
These results provide the fi  rst evidence that EDHF-mediated responses are dependent on 
the NOSs system in mouse mesenteric arteries. 
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    RESULTS   
  Endothelium-dependent relaxations and hyperpolarizations 
in WT and NOS      /      mice 
  In mesenteric arteries from WT mice of both genders, endo-
thelium-dependent relaxations in response to acetylcholine 
(ACh) were highly resistant to indomethacin (10      5   M) or N       -
nitro-  l  -arginine   (l  -NNA; 10      4   M), but were markedly inhib-
ited by a combination of 100 nM charybdotoxin (an inhibitor 
of large- and intermediate-conductance calcium-activated po-
tassium [K  Ca  ] channels) and 1   μ  M apamin (an inhibitor of 
small-conductance K  Ca   channels), indicating a primary role of 
EDHF in endothelium-dependent relaxations in those resis-
tance vessels (  Fig. 1, A and E  ).   On the other hand, in both 
genders of eNOS      /     , n/eNOS      /     , and n/i/eNOS      /      mice, 
NO-mediated relaxations were absent as expected, and whole 
endothelium-dependent relaxations were reduced in accor-
dance with the number of disrupted NOS genes (  Fig. 1, B-D 
and F-H  ).   Fig. 1 (I and J)   shows the relative contribution of 
EDHF to endothelium-dependent relaxations of mesenteric 
arteries from male (  Fig. 1 I  ) and female (  Fig. 1 J  ) WT and the 
three genotypes of NOS      /      mice. Importantly, EDHF-medi-
ated relaxations were progressively reduced in accordance with 
the number of disrupted NOS genes in both genders compared 
with WT mice, and EDHF-mediated relaxations were approx-
imately halved in eNOS      /      mice, further reduced in n/
eNOS      /      mice, and totally absent in n/i/eNOS      /      mice (  Fig. 1, 
I and J  ). Electrophysiological recordings of membrane poten-
tials with the microelectrode technique in mesenteric arteries 
demonstrated that endothelium-dependent hyperpolarizations 
to ACh (10      5   M) in male mice in the presence of indometha-
cin (10      5   M) and   l  -NNA (10      4   M) were also progressively at-
tenuated in accordance with the number of disrupted NOS 
genes (  Fig. 1 K  ). 
  In contrast, in the aorta, endothelium-dependent relaxations 
to ACh were mainly mediated by NO in WT mice (  Fig. 2, A 
and E  ) and were totally absent in all three genotypes of NOS      /      
mice of both genders (  Fig. 2, B-D and F-H  ).   
  Endothelium-independent relaxations in WT 
and NOS      /      mice 
  Endothelium-independent relaxations to sodium nitroprusside 
(SNP; an NO donor) were rather enhanced in mesenteric ar-
teries from the three genotypes of NOS      /      mice of both gen-
ders compared with WT mice (  Fig. 3, A and B  ), whereas those 
to NS-1619 (an opener of the large-conductance K  Ca   channels) 
were preserved (  Fig. 3, C and D  ).   Endothelium-independent 
relaxations to SNP and NS-1619 of the aorta were preserved 
in all three genotypes of NOS      /      mice of both genders 
(  Fig. 3, E-H  ). 
  Immunoreactivity and protein expression of NO synthases 
  We performed immunostaining for the three NOS isoforms to 
examine their localization in mesenteric arteries of WT and the 
three genotypes of NOS      /      mice. In WT mice, the immuno-
reactivity of eNOS and nNOS, but not that of iNOS, was noted 
mainly in the endothelium, and in eNOS      /      and n/eNOS      /      
Indeed, some EDHF-mediated responses still remain in sin-
gly eNOS      /      mice, and the remaining responses are also 
sensitive to catalase that dismutates H  2  O  2   to form water and 
oxygen (  14  ). 
  NO is synthesized by three distinct NOS isoforms (neu-
ronal NOS [nNOS], inducible [iNOS], and eNOS) that 
compensate each other. Although both eNOS and nNOS are 
constitutively expressed, iNOS is usually expressed in the 
context of infl  ammatory responses, such as sepsis, cytokine 
release, and heart failure (  23, 24  ). In the vasculature, eNOS is 
a well-established primary source of NO that plays an impor-
tant role in the regulation of systemic blood pressure, blood 
fl  ow, and regional vascular tone (  2, 25  –  27  ), whereas NO de-
rived from nNOS or iNOS also plays an important role in 
vasodilatation and vascular protection under various patho-
logical conditions (  28  –  31  ). A critical determinant of NOS 
activity is the availability of tetrahydrobiopterin (BH  4  ), a NOS 
cofactor (  32  ). When BH  4   levels are inadequate, the enzy-
matic reduction of molecular oxygen by NOS is no longer 
coupled to   l  -arginine oxidation, resulting in generation of 
superoxide anions rather than NO, thus contributing to vas-
cular oxidative stress and endothelial dysfunction. BH  4   bio-
availability in the vasculature appears to be regulated at the 
level of biosynthesis by the rate-limiting enzyme GTP cyclo-
hydrolase-1 (GTPCH1). In contrast, administration of the BH  4   
precursor sepiapterin ameliorates endothelial dysfunction in 
ApoE-defi  cent mice (  33  ). 
  We have recently generated n/i/eNOS      /      mice, which 
are unexpectedly viable and appear normal, but their sur-
vival and fertility rates are markedly reduced compared with 
WT mice (  34  ). They also exhibit marked hypotonic poly-
uria, polydipsia, and renal unresponsiveness to the anti-
diuretic hormone vasopressin, all of which are characteristics 
consistent with nephrogenic diabetes insipidus ( 34  ). Further-
more, our recent study indicates that n/i/eNOS      /      mice 
spontaneously develop cardiovascular diseases, including hy-
pertension, dyslipidemia, and myocardial infarction, resem-
bling metabolic syndrome in humans (  35  ). These results 
suggest that NOSs system plays an important role in main-
taining homeostasis. 
  Both NO- and EDHF-mediated responses are impaired by 
various risk factors for atherosclerosis (  2, 5  ) and, conversely, the 
treatments of those risk factors ameliorate both NO- and 
EDHF-mediated responses (  36, 37  ). In various pro-atherogenic 
conditions, the production of reactive oxygen species is in-
creased, whereas NO-mediated relaxations are reduced. EDHF-
mediated relaxations are temporarily enhanced to compensate 
for the reduced NO-mediated relaxations; however, during the 
progression of atherosclerosis, the EDHF-mediated responses 
are also subsequently reduced (  2  ). 
  These lines of evidence led us to hypothesize that EDHF-
mediated responses are closely coupled to the whole endo-
thelial NOSs system. In this study, we thus examined the 
contribution of the whole endothelial NOSs system to EDHF-
mediated responses, using eNOS      /     , n/eNOS      /     , and n/i/
eNOS      /      mice (  34  ). JEM VOL. 205, September 1, 2008 
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  Effect of antihypertensive treatment on EDHF-mediated 
relaxations in n/i/eNOS      /      mice 
  Systolic blood pressure (mmHg) was signifi  cantly higher in n/
i/eNOS      /      mice (141   ±   3 mmHg) compared with WT mice 
(105   ±   3 mmHg;   n   = 6 each; P   <   0.0001). Although antihy-
pertensive treatment with oral hydralazine for 1 wk normalized 
blood pressure in n/i/eNOS      /      mice (102   ±   2 mmHg), the 
antihypertensive treatment failed to improve EDHF-mediated 
responses in those mice (  Fig. 6, A and B  ).   The antihypertensive 
treatment with hydralazine increased indomethacin-sensitive 
endothelium-dependent relaxations, suggesting an up-regula-
tion of vasodilator prostaglandins (  Fig. 6 A  ). Endothelium-
independent relaxations in response to SNP and NS-1619 
were comparable between n/i/eNOS      /      mice with and those 
without the antihypertensive treatment with hydralazine (  Fig. 6, 
C and D  ). 
  Endothelial H  2  O  2   production 
  Endothelial H  2  O  2   production in mesenteric arteries was evalu-
ated in the experiments using a laser confocal microscope loaded 
with 2    ,7    -dichlorodihydro-fl  uorescein diacetate (DCF), a per-
oxide-sensitive fl  uorescence dye (  14, 21  ). All experiments were 
mice, the expression of nNOS and iNOS was noted, respec-
tively (  Fig. 4 A  ).   In contrast, in n/i/eNOS      /      mice, none of the 
NOS isoforms were noted, as expected (  Fig. 4 A  ). Further-
more, we performed Western blot analysis to quantify the pro-
tein expression of NOS isoforms in the whole mesentery. In 
WT mice, the expression of both eNOS and nNOS was noted, 
whereas that of iNOS was minimal (  Fig. 4 B  ). In eNOS      /      mice, 
the expression of nNOS was again noted, and in n/eNOS      /      
mice, the expression of iNOS was signifi  cantly up-regulated 
compared with WT or eNOS      /      mice (  Fig. 4 B  ). In n/i/
eNOS      /      mice, none of the NOS isoforms were noted, as 
expected (  Fig. 4 B  ). 
  Activities and protein expressions of scavenging enzymes 
in mouse mesenteric arteries 
  In the whole mesenteric tissue, the activities of scavenging en-
zymes, including Cu,Zn-SOD (  Fig. 5 A  ), catalase (  Fig. 5 B  ), 
and glutathione peroxidase (GPx;   Fig. 5 C  ), were all signifi  -
cantly enhanced in n/i/eNOS      /      mice compared with WT 
mice.   On the other hand, the protein expression of Cu,Zn-
SOD (  Fig. 5 D  ), catalase (  Fig. 5 E  ), and GPx (  Fig. 5 F  ) were all 
comparable between WT and n/i/eNOS      /      mice. 
    Figure 1.     Reduced EDHF-mediated relaxations and hyperpolarizations of mesenteric arteries in both genders of NOS      /      mice.  Endothelium-
dependent relaxations of mesenteric arteries from male (A  –  D) and female (E  –  H) mice are shown (  n   = 6 each). In both genders of WT mice (A and E), endo-
thelium-dependent relaxations were mainly mediated by EDHF, whereas in those of eNOS     /     (B and F), n/eNOS     /     (C and G), and n/i/eNOS     /     mice 
(D and H) mice, the relaxations were progressively reduced in accordance with the number of disrupted NOS genes. Indo, indomethacin; CTx, charybdotoxin; 
Apm, apamin. *, P   <   0.05; **, P   <   0.01. Relative contribution of EDHF in male (I) and female (J) mice to the whole endothelium-dependent relaxations to 
ACh were progressively reduced in accordance with the number of disrupted NOS genes. *, P   <   0.05. (K) Endothelium-dependent hyperpolarizations to 
ACh of mesenteric arteries from male mice also were progressively attenuated in accordance with the number of disrupted NOS genes (  n   = 6 each). *, P   <   
0.05. Data are shown as the mean   ±   SEM.     2056 NITRIC OXIDE SYNTHASES AND EDHF IN MICE   | Takaki et al. 
fl  uorescence intensity was abolished (  Fig. 7 D  ). Importantly, the 
extent of the ACh-induced increase in the DCF fl  uorescence 
intensity at the endothelial layer was absent in n/i/eNOS      /      
mice, regardless of the presence or absence of the antihyperten-
sive treatment with hydralazine (  Fig. 7, E and F  ).   Fig. 7 G   sum-
marizes the quantitative analysis of relative DCF fl  uorescence 
intensity in response to ACh in WT and n/i/eNOS      /      mice. 
performed in the presence of indomethacin (10      5   M) and 
  l  -NNA (10      4   M). In this system, the endothelial monolayer 
was clearly distinguished from underlying smooth muscle cell 
layer (  Fig. 7, A-C  ).   In WT mice, ACh caused a signifi  cant in-
crease in the DCF fl  uorescence intensity in endothelial cells 
6 min after the application (  Fig. 7 B  ). When arterial strip was 
pretreated with catalase, the ACh-induced increase in DCF 
    Figure 2.     Endothelium-dependent relaxations of the aorta in both genders of mice.   Endothelium-dependent relaxations of the aorta from male 
(A  –  D) and female (E  –  H) mice are shown (  n   = 5 each). In the aorta of WT mice (A and E), endothelium-dependent relaxations to ACh were resistant to in-
domethacin, but were markedly inhibited by   L  -NNA, indicating a primary role of NO. In contrast, in the eNOS     /     (B and F), n/eNOS     /     (C and G), and n/i/
eNOS     /     (D and H) mice, endothelium-dependent relaxations in response to ACh were totally absent. **, P   <   0.01. Data are shown as the  mean   ±   SEM.   
    Figure 3.     Vascular smooth muscle responses of mesenteric arteries and aorta in both genders of mice.   Endothelium-independent relaxations of 
mesenteric arteries in response to SNP (an NO donor) in male (A) and female (B) mice, and those to NS-1619 (an opener of K  Ca   channels) in male (C) and 
female (D) mice, are shown (  n   = 6 each). The relaxations to SNP were signifi  cantly enhanced in both genders of the three genotypes of NOS     /     mice  as 
compared with WT mice (A and B), whereas those to NS-1619 were unaltered (C and D). Endothelium-independent relaxations of the aorta in response to 
SNP in male (E) and female (F) mice, and those to NS-1619 in male (G) and female (H) mice are shown (  n   = 5 each). Those vasodilator responses of vascu-
lar smooth muscle were preserved in both genders of the three genotypes of NOS     /     mice compared with WT mice. Data are shown as the mean   ±   SEM.     JEM VOL. 205, September 1, 2008 
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muscle cell layer (  Fig. 7, H-L  ). In WT mice, ACh caused a signi-
fi  cant increase in the DHE fl  uorescence intensity in endothelial 
cells 5 min after the application (  Fig. 7, H, I, and M  ). Impor-
tantly, in n/i/eNOS      /      mice, the endothelial production of 
superoxide in response to ACh was absent (  Fig. 7, K, L, and M  ). 
  No involvement of pathological NOS uncoupling 
in EDHF-mediated relaxations 
  We examined whether pathological NOS uncoupling caused 
by BH  4   defi  ciency is involved in the EDHF-mediated relax-
ations in WT mice. Sepiapterin (precursor of BH  4  , 10      4   M) 
and 2,4-diamino-6-hydroxypyrimidine (DAHP; GTPCH1 
inhibitor, 10      2   M) had no acute eff  ects on EDHF-mediated 
relaxations (in the presence of indomethacin and   l  -NNA) of 
mesenteric arteries from WT mice (  Fig. 8, A and B  ).   Further-
more, we measured tissue concentrations of BH  4   and dihy-
drobiopterin (BH  2  ) in the aorta and small mesenteric arteries 
in mice and used the BH  4  /BH  2   ratio as an index of BH  4   bio-
availability (  39  ). As shown in   Fig. 8 C  , the BH  4  /BH  2   ratio, 
an index of BH  4   bioavailability, was not reduced in mesen-
teric arteries, but instead tended to be increased as compared 
with the aorta. These results indicate that pathological eNOS 
uncoupling is not involved in the production of superoxide 
anions in normal mouse mesenteric arteries. 
    DISCUSSION   
  In this study, we were able to demonstrate that endothelial 
NOSs system has diverse vasodilator functions depending on 
  Endothelial superoxide production 
  Endothelial superoxide production in mesenteric arteries was 
evaluated using a laser confocal microscope loaded with dihy-
droethidium (DHE), an oxidant fl  uorescent dye (  38  ). All ex-
periments were performed in the presence of indomethacin 
(10      5   M) and   l  -NNA (10      4   M). In this system, the endothelial 
monolayer was clearly distinguished from the underlying smooth 
    Figure 4.     Immunostaining and Western blotting for NOS isoforms.   (A) Immunostaining for three NOS isoforms and negative control of mesenteric 
arteries from WT and three genotypes of NOS     /     mice. The magnifi  cation (400  ×  ) is the same in all fi  gures. Endothelial immunoreactivities of nNOS and 
iNOS in mesenteric arteries were observed in eNOS     /     and  n/eNOS    /     mice, respectively, whereas in n/i/eNOS     /     mice, none of the NOS isoforms were 
noted. Bar, 10   μ  m. (B) Protein expression of three NOS isoforms in the whole mesenteric artery from WT and three genotypes of NOS     /     mice  ( n   = 5 
each). In WT mice, protein expression of both eNOS and nNOS was noted, and in eNOS     /     mice, that of nNOS alone was noted. In n/eNOS     /     mice,  the 
expression of iNOS was signifi  cantly up-regulated, whereas in n/i/eNOS     /     mice, none of the NOS isoforms were noted, as expected. *, P   <   0.05. Data are 
shown as the mean   ±   SEM.     
    Figure 5.     Activities and expressions of scavenging enzymes in 
mouse mesenteric arteries.   The activities (top row) and protein expres-
sions (bottom row) of Cu,Zn-SOD (A and D), catalase (B and E), and GPx 
(C and F) in the whole tissue of mesentery from WT and n/i/eNOS     /     mice 
are shown (  n   = 5 each). The vascular activities of the enzymes were all 
signifi  cantly enhanced in n/i/eNOS     /     mice compared with WT mice, 
whereas the protein expressions of the enzymes were all comparable 
between WT and n/i/eNOS     /     mice. *, P   <   0.05 vs. WT. Data are shown as 
the mean   ±   SEM.     2058 NITRIC OXIDE SYNTHASES AND EDHF IN MICE   | Takaki et al. 
mal conditions from reductase domain and only when un-
coupled (e.g., BH  4   and/or   l  -arginine depletion) from the 
oxidase domain, and that   l  -arginine analogues only inhibit 
the latter process (  40  ). Indeed, we were able to demonstrate 
that endothelial superoxide generation was signifi  cantly in-
creased in response to ACh in WT mice, whereas in n/i/
eNOS      /      mice, this endothelial production of superoxide to 
ACh was absent, indicating that superoxide anions derived 
from NOS leads to endothelial formation of EDHF/H  2  O  2   
in WT mice. On the other hand, the residual dilation after 
blocking all three pathways in WT mice was greater than 
when blocking the same pathways in eNOS      /      mice. It has 
been reported that   l  -NNA dose not completely inhibit NOSs 
(  41, 42  ). It is thus conceivable that the residual dilation after 
blocking all three pathways in male WT mice may refl  ect un-
inhibited NO-mediated responses. 
  In this study, in n/eNOS      /      mice, some EDHF-mediated 
responses remained. It is known that iNOS is commonly in-
duced by endotoxins and cytokines, producing NO indepen-
dently of calcium infl  ux. However, it has also been reported 
that the activation of iNOS requires Ca  2+   (  43, 44  ). Further-
more, in our study, the expression of iNOS in mesentery was 
signifi  cantly increased in n/eNOS      /      mice compared with 
WT or eNOS      /      mice. These fi  ndings suggest that residual 
EDHF-mediated dilation in n/eNOS      /      mice could be caused 
by Ca  2+  -dependent iNOS activity. 
  It has been reported that in skeletal muscle arterioles of fe-
male eNOS      /      mice, EDHF-mediated responses were rather 
increased (  45  ). However, in this study, no such gender-specifi  c 
differences were noted in the whole range of genotypes of 
NOSs      /      mice. The discrepancy between the previous study 
(  45  ) and this study might be caused by the diff  erences in blood 
vessels used (skeletal muscle arterioles vs. small mesenteric ar-
teries), method of blood vessel preparation used (pressurized 
vs. nonpressurized) and analysis performed for the EDHF re-
sponses (pharmacological analysis alone vs. pharmacological/
electrophysiological study). 
  The reduced EDHF-mediated responses in NOSs      /      mice 
could be caused by mechanism(s) other than reduced produc-
tion of the factor. First, vasodilator properties of vascular 
smooth muscle might be impaired in NOSs      /      mice. How-
ever, in the NOSs      /      mice of both genders, endothelium-
independent relaxations to NS-1619, a K  Ca   opener, were 
preserved and those to SNP were rather enhanced, a fi  nding 
consistent with the previous reports with eNOS      /      mice 
(  14, 46  ). Second, the reduced EDHF-mediated responses in n/
i/eNOS      /      mice could be a result of the elevated blood pres-
sure. However, the antihypertensive treatment with hydrala-
zine failed to improve the reduced EDHF-mediated relaxations 
in those mice. Third, the enhanced production of superoxide 
anions in n/i/eNOS      /      mice from intracellular sources other 
than eNOS might interfere with EDHF responses. Indeed, we 
have confi  rmed that cardiac superoxide production is markedly 
enhanced in our n/i/eNOS      /      mice (unpublished fi  ndings) 
and, in this study, we also noted that the activities of superoxide 
anion scavenging enzymes, including Cu,Zn-SOD, catalase, 
the vessel size, mainly contributing to EDHF/H  2  O  2   responses 
in microvessels (small mesenteric arteries) while serving as a 
NO-generating system in large arteries (the aorta;   Fig. 9  ).   
Thus, the study provides a novel concept on the diverse roles 
of the endothelial NOSs system to modulate vascular tone, 
which is apparently dependent on vessel size (  Fig. 9  ). To the 
best of our knowledge, this is the fi  rst study that demonstrates 
that disruption of certain genes (NOSs) abolishes EDHF-me-
diated responses. 
  In WT mice, endothelium-dependent relaxations of small 
mesenteric arteries were mainly mediated by EDHF, whereas 
those of the aorta were mediated by NO, a fi  nding that is 
consistent with our previous studies (  2, 4, 14  ). Interestingly, 
EDHF-mediated relaxations were progressively reduced in ac-
cordance with the number of disrupted NOS genes in mesen-
teric arteries and were absent in n/i/eNOS      /      mice, indicating 
that EDHF-mediated relaxations are totally mediated by the 
endothelial NOSs system in mouse mesenteric arteries. 
  In this study, after the classical defi  nition of EDHF (  1  –  3  ), 
we evaluated EDHF-mediated responses in mouse mesen-
teric arteries in the presence of indomethacin and   l  -NNA. It 
is known that eNOS generates superoxide anions under nor-
    Figure 6.     Failure of antihypertensive therapy to improve the re-
duced EDHF-mediated responses in n/i/eNOS      /      mice.   (A) In hydrala-
zine-treated n/i/eNOS     /     mice, endothelium-dependent relaxations of 
mesenteric arteries were improved, but were markedly inhibited by indo-
methacin (  n   = 4). **, P   <   0.01. (B) Quantitative analysis demonstrated that 
the antihypertensive treatment with hydralazine failed to improve the 
reduced EDHF-mediated responses (  n   = 4 each). **, P   <   0.01. Endothe-
lium-independent relaxations in response to SNP (C) and NS-1619 (D) 
were comparable between n/i/eNOS     /     mice with and those without the 
antihypertensive treatment with hydralazine (  n   = 4  –  6). Data are shown as 
the mean   ±   SEM.     JEM VOL. 205, September 1, 2008 
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ACh-induced relaxation is absent, indicating that a suffi   cient 
amount of functional NOS to cause vasodilation does not exist 
in VSMC. Furthermore, in this study, the eNOS immuno-
reactivity was markedly less in the vascular smooth muscle 
compared with the endothelial layer (  Fig. 4  ). 
  The confocal microscopy study with DCF and DHE staining 
demonstrated that endothelial production of H  2  O  2   and superox-
ide in response to ACh was absent in n/i/eNOS      /      mice, further 
confi  rming the important role of the endothelial NOSs system in 
the synthesis of EDHF/H  2  O  2  . We have previously demonstrated 
that catalase-sensitive EDHF responses and endothelial H  2  O  2   pro-
duction still remained in singly eNOS      /      mice (  14  ). Thus, these 
fi  ndings support our hypothesis that superoxide anions derived 
from endothelial NOSs system appear to be the main source of 
EDHF/H  2  O  2   production from the endothelium. 
and GPx, were all enhanced. This issue needs to be further 
examined in future studies. 
  In this study, in WT mice, the eNOS immunoreactivity 
was noted mainly in the endothelium of mesenteric arteries, 
whereas in eNOS      /     and n/eNOS      /      mice, immunoreactiv-
ities of other NOSs that had not been disrupted were ob-
served in the endothelium of the blood vessels. In n/i/eNOS      /      
mice, none of the NOS isoforms was noted, as expected. 
These results support our hypothesis that the endothelial 
NOSs system is substantially involved in EDHF-mediated re-
sponses. On the other hand, in vascular smooth muscle cells 
(VSMCs), muscarinic receptors exist and it is possible that 
ACh might act there to elicit vasomotor responses through 
EDHF. However, we (  14  ) and others (  47  ) confi  rmed that in 
endothelium-denuded mesenteric arteries of normal mice, 
    Figure 7.     Endothelial production of H  2  O  2   and superoxide in response to ACh.   DCF image at the endothelial layer of a WT mouse under basal con-
ditions (A) and after application of ACh (B), and that at the smooth muscle (SM) layer of a WT mouse after ACh application (C). (D) Catalase abolished the 
endothelial H  2 O 2   production to ACh, and the production was absent in an n/i/eNOS     /     mouse without (E) and in one with hydralazine treatment (F). 
(G) Quantitative analysis of the endothelial H  2 O 2   production  ( n   = 3  –  5). **, P   <   0.01. DHE image at the endothelial layer of a WT mouse under basal conditions 
(H) and after application of ACh (I), and that at SM layer of a WT mouse after ACh application (J). Endothelial production of superoxide was absent in an 
n/i/eNOS     /     mouse (K and L). (M) Quantitative analysis of the endothelial superoxide production (  n   = 3 each). *, P   <   0.05. Bar, 20   μ  m. Data are shown as 
the mean   ±   SEM.     2060 NITRIC OXIDE SYNTHASES AND EDHF IN MICE   | Takaki et al. 
which should be enough to cause EDHF-type vasodilatation 
(  16  ). Third, although we were able to demonstrate the impor-
tant role of endothelial NOSs system in EDHF-mediated re-
sponses in vitro, the in vivo importance of the system remains 
to be examined in future studies. Fourth, vascular endothelial 
cells have several intracellular sources other than NOSs to pro-
duce superoxide anions that are dismutated to H  2  O  2  , including 
NAD(P)H oxidase, mitochondrial electron transport chain, 
lipoxygenase, and xanthine oxidase (  50  ). In this study, we did 
not examine the contribution of superoxide anions derived from 
intracellular sources other than the endothelial NOSs system to 
EDHF-mediated relaxations. Fifth, although we demonstrated 
the important role of endothelial NOSs system in EDHF-medi-
ated responses, we did not test our hypothesis using endo-
thelial cell-specifi  c NOSs      /      mice. In this study, however, we 
examined endothelium-dependent and endothelium-inde-
pendent responses separately, and confi  rmed that endothelium-
independent responses were unaltered in the three genotypes 
of NOS      /      mice. 
  This study may have important clinical implications. EDHF 
plays an important role in human arteries, especially in mi-
crovessels, and its vasodilator eff  ects are impaired in several dis-
ease states, such as aging and hypercholesterolemia, with a 
resultant microvascular dysfunction (  5  ). Our n/i/eNOS      /      
mice are characterized by the phenotypes resembling meta-
bolic syndrome in humans, which is not evident in singly 
eNOS      /      mice (  35  ). Thus, the novel concept of this study on 
the diverse roles of endothelial NOSs system may provide the 
basis of new therapeutic strategy for the treatment and preven-
tion of cardiovascular diseases (  Fig. 9  ). 
  In conclusion, this study provides a novel concept on the 
diverse roles of the endothelial NOSs system contributing to 
  Recent evidence suggests that BH  4  -dependent eNOS un-
coupling may be an important mechanism that causes endo-
thelial dysfunction and increased superoxide production in 
vascular diseases (  48, 49  ). However, in this study with normal 
mouse mesenteric arteries, sepiapterin or DAHP had no acute 
eff  ects on EDHF-mediated relaxations. Furthermore, it has 
been reported that endothelial production of superoxide an-
ions from eNOS is noted even under physiological conditions 
in the absence of BH  4   defi  ciency (  40  ). Indeed, in this study, we 
were able to demonstrate that the BH  4  /BH  2   ratio was compa-
rable between the aorta and mesenteric arteries in WT mice, 
suggesting that superoxide from physiological (coupled) NOSs 
is the major source of EDHF/H  2  O  2   with preserved BH  4   bio-
availability (  Fig. 9  ). 
  Several limitations should be mentioned for this study. First, 
in this study, although we were able to demonstrate the diverse 
roles of endothelial NOSs system depending on the vessel size, 
the detailed molecular mechanism(s) for it remains to be eluci-
dated in future studies (  Fig. 9  ). Second, although we were able 
to demonstrate the endothelial production of H  2  O  2   and super-
oxide anions using confocal microscopy with DCF and DHE, 
respectively, we were unable to quantify the H  2  O  2   and super-
oxide production caused by technical diffi   culties and limited 
availability of mesenteric microvessels for the measurement. 
However, we have previously demonstrated with an electron 
spin resonance method that endothelial cells produce H  2  O  2  , at 
least in micromolar concentrations, in porcine coronary micro-
vessels under physiological conditions upon agonist stimulation, 
    Figure 9.     Summary of this study.   NO mediates vascular relaxation of 
relatively large, conduit arteries (e.g., aorta and epicardial coronary arteries), 
whereas EDHF plays an important role in modulating vascular tone in small, 
resistance arteries (e.g., small mesenteric arteries and coronary microvessels). 
All three NOS isoforms (nNOS, iNOS, and eNOS), especially eNOS, produce 
NO and superoxide anions, and the latter is dismutated by Cu,Zn-SOD to 
EDHF/H  2 O 2  . EDHF hyperpolarizes VSMCs by opening K  Ca   channels, and then 
elicits vasodilation. On the other hand, superoxide anions from uncoupled 
NOSs may not signifi  cantly contribute to EDHF-mediated relaxations. 
Collectively, this study provides a novel concept on the diverse roles of 
endothelial NOSs system mainly contributing to the EDHF/H  2 O 2   responses  in 
microvessels while serving as NO-generating system in large arteries.    
    Figure 8.     No involvement of NOS uncoupling in EDHF-mediated 
responses.   In the presence of indomethacin and   L  -NNA, the precursor of 
BH  4  , sepiapterin (A) or the GTPCH1 inhibitor DAHP (B) did not change 
EDHF-mediated relaxations of mesenteric arteries from WT mice (  n   =  6 – 7). 
(C) The BH  4 /BH 2   ratio was comparable between the aorta and mesenteric 
arteries from WT mice (  n   = 4). To generate suffi  cient amount of total 
protein, the aorta and mesenteric arteries were pooled from three mice. 
This pool was considered as   n   = 1. 4 individual pools of a total of 12 dif-
ferent mice were used to extract protein, which yielded a total of   n   =  4. 
Data are shown as the mean   ±   SEM.     JEM VOL. 205, September 1, 2008 
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served using a laser confocal microscope (LSM 510 META; Carl Zeiss, Inc.) at 
an excitation wavelength of 488 nm and an emission wavelength of 520 nm at 
25  °  C (  14, 21  ) or (C1; Nikon) at an excitation wavelength of 543 nm and an 
emission wavelength of 590 nm (  38  ). Fluorescence images of the endothelium 
were obtained before and 6 min (DCF) or 5 min (DHE) after application of 
10   μ  M ACh. Relative fl  uorescence intensity was calculated using images ob-
tained under basal conditions without ACh. The inhibitory eff  ect of pretreat-
ment with catalase (1,250 U/ml) on the ACh-induced increase in fl  uorescence 
intensity was determined (  14  ). 
  BH  4   and BH  2   measurement.     Isolated vessels were homogenized in 0.5 M 
perchloric acid containing 0.1 mM disodium EDTA and 0.1 mM Na  2  S  2  O  3   for 
protein separation. After centrifugation (20,000  ×   g for 10 min) and fi  ltration, 
we measured BH  4   and BH  2   concentrations using HPLC. In brief, by post-col-
umn NaNO  2   oxidation with a reversed-phase ion-pair LC system, pterins 
were detected fl  uorometrically at a wavelength of 350 nm for excitation and 
440 nm for emission (LC-10 series; Shimadzu) (  52  ). 
  Drugs and solution.     The ionic composition of Krebs solution was as follows 
(mM); Na  +   144, K  +   5.9, Mg  2+   1.2, Ca  2+   2.5, H  2  PO  4          1.2, HCO  3          24, Cl        
129.7, and glucose 5.5. DCF and DHE were obtained from Invitrogen. Other 
drugs were purchased from Sigma-Aldrich. Antibodies to GPx and     -actin 
were obtained from Abcam, catalase antibody from Epitomics Inc., and 
Cu,Zn-SOD antibody from Stressgen Biotechnologies Corp. 
  Statistical analysis.     Data are shown as the mean   ±   SEM. Dose  –  response 
curve was analyzed by two-way analysis of variance [ANOVA] followed by 
Scheff  e  ’  s post-hoc test for multiple comparisons. The relative contribution of 
EDHF to the endothelium-dependent relaxations was analyzed by Bonferroni/
Dunn test. Other values were analyzed by paired and unpaired Student  ’  s   t   test 
or one-way ANOVA. P   <   0.05 was considered to be statistically signifi  cant. 
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scribed (  14, 21  ). The contributions of vasodilator prostaglandins, NO, and 
EDHF to ACh-induced endothelium-dependent relaxations were deter-
mined by the inhibitory eff  ect of indomethacin,   l  -NNA, and a combination 
of charybdotoxin and apamin, respectively (  14, 21  ). To examine the eff  ect 
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